A versatile drug delivery system targeting senescent cells
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Senescent cells accumulate in multiple aging‐associated diseases, and eliminating these cells has recently emerged as a promising therapeutic approach. Here, we take advantage of the high lysosomal β‐galactosidase activity of senescent cells to design a drug delivery system based on the encapsulation of drugs with galacto‐oligosaccharides. We show that gal‐encapsulated fluorophores are preferentially released within senescent cells in mice. In a model of chemotherapy‐induced senescence, gal‐encapsulated cytotoxic drugs target senescent tumor cells and improve tumor xenograft regression in combination with palbociclib. Moreover, in a model of pulmonary fibrosis in mice, gal‐encapsulated cytotoxics target senescent cells, reducing collagen deposition and restoring pulmonary function. Finally, gal‐encapsulation reduces the toxic side effects of the cytotoxic drugs. Drug delivery into senescent cells opens new diagnostic and therapeutic applications for senescence‐associated disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“One approach stems from the increase in lysosomal mass and senescence-associated β-galactosidase activity in many senescent cells, whereby galacto-oligosaccharide-coated nanoparticles and β-galactosidase-activated prodrugs appear to eliminate at least some of these cells92,93.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“Nanoparticles containing either fluorophores or cytotoxic agents coated with galacto-oligosaccharides were found to preferentially deliver cytotoxic cargo to senescent cells because of the higher level of SA-β-gal activity in these cells218.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [218]
The cited source says what the claim attributes to it.
In the citing paper
“A senescence transcriptional signature could enable rapid detection of senescent cells, and multiple such gene sets have been described132–136,139.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“Galacto-oligosaccharide encapsulated nanoparticles (GalNP) containing cytotoxic or senolytic drugs (Muñoz-Espín et al. 2018) and galactose-derived prodrugs display senolytic properties (González-Gualda et al. 2020; Guerrero et al. 2020)”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Muñoz-Espín et al. 2018
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Spatial omics has not yet been used extensively for senescence research but is in development132–136.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [134]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
InfluentialThe Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialUltrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialOrdered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275 · cited 4×
“For the synthesis of the mesoporous silica MCM-41 scaffolds (Kresge et al, 1992), N-cetyltrimethylammonium bromide (CTAB, Sigma, #H6269) was first dissolved in 480 ml of deionized water at 2.74 mM.”
BackgroundMethodInfluentialTrapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218 · cited 1×
“In this regard, it is relevant to mention that macrophages are known to metabolize nanoparticles (Wilhelm et al, 2016) and can present SAbGal activity without actually being senescent (Hall et al, 2017).”
BackgroundNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 1×
“Published under the terms of the CC BY 4.0 license EMBO Molecular Medicine 10: e9355 | 2018 1 of 18 processes associated with chemotherapy, and extends longevity (Baker et al, 2016; Childs et al, 2016; Demaria et al, 2017).”
MethodInfluentialCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Self-citationThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 3×
“Importantly, senescent cells present vulnerabilities to particular small molecule inhibitors, known as “senolytics”, that trigger apoptosis preferentially in senescent cells (Zhu et al, 2015).”
Background
Cited by
Items 101–200 of 339
Senescence and the Aging Immune System as Major Drivers of Chronic Kidney Disease
Schroth, J., Thiemermann, C., & Henson, S. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.564461 · Cited by 59
Senolytics: A Translational Bridge Between Cellular Senescence and Organismal Aging
Thoppil, H., & Riabowol, K. T. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00367 · Cited by 64
“One example is a drug delivery system utilizing encapsulation of cytotoxic drugs with galacto-oligosaccharides (Muñoz-Espín et al., 2018).”
BackgroundThe Jekyll and Hyde of Cellular Senescence in Cancer
Demirci, D., Dayanc, B., Mazi, F. A., & Şentürk, Ş. (2021) · Cells · doi:10.3390/cells10020208 · Cited by 69
The challenge of identifying senescent cells
Gil, J. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01267-w · Cited by 58
Osteoclasts and osteoarthritis: Novel intervention targets and therapeutic potentials during aging
Wang, H., Yuan, T., Wang, Y., Liu, C., Li, D., Li, Z., & Sun, S. (2024) · Aging Cell · doi:10.1111/acel.14092 · Cited by 69
Targeting normal and cancer senescent cells as a strategy of senotherapy
Sikora, E., Bielak-Zmijewska, A., & Mosieniak, G. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100941 · Cited by 56
Chakrabarty, A., Chakraborty, S., Bhattacharya, R., & Chowdhury, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.674354 · Cited by 62
Calabrò, A., Accardi, G., Aiello, A., Caruso, C., Galimberti, D., & Candore, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031792 · Cited by 53
Xiong, J., Dong, L., Lv, Q., Yin, Y., Zhao, J., Ke, Y., Wang, S., Zhang, W., & Wu, M. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1772 · Cited by 66
“160 Additional, to mitigate the systemic toxicity associated with senolytic navitoclax while enhancing the clearance of senescent breast cancer cells, nano-encapsulated navitoclax conjugated to galacto-oligosaccharides demonstrated significant anti-tumour efficacy alongside a reduced side effect…”
BackgroundLuo, J., Sun, T., Liu, Z., Liu, Y., Liu, J., Wang, S., Shi, X., & Zhou, H. (2025) · International Journal of Oral Science · doi:10.1038/s41368-025-00380-w · Cited by 71
Cellular senescence promotes progenitor cell expansion during axolotl limb regeneration
Yu, Q., Walters, H. E., Pasquini, G., Pal Singh, S., Lachnit, M., Oliveira, C. R., León-Periñán, D., Petzold, A., Kesavan, P., Subiran Adrados, C., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.09.009 · Cited by 52
Self-citationSchwab, N., Taskina, D., Leung, E., Innes, B. T., Bader, G. D., & Hazrati, L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1027116 · Cited by 59
“Consistent with these previous findings, this study has used scRNAseq to show that neurons are indeed enriched for pathways involved in cellular senescence including the DNA damage response, cell-cycle arrest mediated by p53, p21, and p16, p38MAPK signaling, and production of pro-inflammatory chemokines and cytokines…”
BackgroundInfluentialSenescent cells in cancer therapy: why and how to remove them
Zhang, J., Zhang, D., & Yu, B. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.002 · Cited by 59
RNA Biology Provides New Therapeutic Targets for Human Disease
Harries, L. W. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00205 · Cited by 55
“RNA modifications can influence gene expression by a number of mechanisms, including influencing RNA structure, recruiting other regulatory proteins (e.g., splicing factors, RNA binding proteins involved in control of stability) or moderation of translation (Nachtergaele, 2017).”
Nagesh, P. K. B., Chowdhury, P., Hatami, E., Kumari, S., Kashyap, V. K., Tripathi, M. K., Wagh, S., Meibohm, B., Chauhan, S. C., Jaggi, M., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b14738 · Cited by 48
Transient metabolic improvement in obese mice treated with navitoclax or dasatinib/quercetin
Sierra-Ramirez, A., López-Aceituno, J. L., Costa-Machado, L. F., Plaza, A., Barradas, M., & Fernandez-Marcos, P. J. (2020) · Aging · doi:10.18632/aging.103607 · Cited by 47
Duro-Sánchez, S., Nadal-Serrano, M., Lalinde-Gutiérrez, M., Arenas, E. J., Bernadó Morales, C., Morancho, B., Escorihuela, M., Pérez-Ramos, S., Escrivá-de-Romaní, S., Gandullo-Sánchez, L., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0787 · Cited by 45
Chemical Strategies for the Detection and Elimination of Senescent Cells
García-Fleitas, J., García‐Fernández, A., Martí‐Centelles, V., Sancenón, F., Bernardos, A., & Martínez‐Máñez, R. (2024) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00794 · Cited by 47
Self-citationCellular senescence in cancer: molecular mechanisms and therapeutic targets
Jin, P., Duan, X., Li, L., Zhou, P., Zou, C., & Xie, K. (2024) · MedComm · doi:10.1002/mco2.542 · Cited by 57
Willobee, B. A., Gaidarski, A. A., Dosch, A. R., Castellanos, J. A., Dai, X., Mehra, S., Messaggio, F., Srinivasan, S., VanSaun, M. N., Nagathihalli, N. S., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-1043 · Cited by 42
“In addition, they have also been shown to induce xenograft regression in multiple tumor cell lines following Rb-dependent senescence induction (45).”
BackgroundTargeting Cellular Senescence for Age-Related Diseases: Path to Clinical Translation
Wyles, S. P., Tchkonia, T., & Kirkland, J. L. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000009669 · Cited by 43
Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells
Morsli, S., Doherty, G. J., & Muñoz-Espín, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111618 · Cited by 42
Self-citationInsights from In Vivo Studies of Cellular Senescence
Prieto, L. I., Graves, S. I., & Baker, D. J. (2020) · Cells · doi:10.3390/cells9040954 · Cited by 41
“These include a peptide that disrupts the interaction of FOXO4 and p53 leading to apoptosis [63], as well as nanoparticles that target senescence-associated β-gal positive cells [64].”
BackgroundEstepa‐Fernández, A., García‐Fernández, A., Lérida‐Viso, A., Blandez, J. F., Galiana, I., Sancenón, F., Orzáez, M., & Martínez‐Máñez, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106628 · Cited by 43
Self-citationSelective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs
Chang, M., Gao, F., Gnawali, G. R., Xu, H., Dong, Y., Meng, X., Li, W., Wang, Z., Lopez, B., Carew, J. S., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00152 · Cited by 44
Genome-Protecting Compounds as Potential Geroprotectors
Proshkina, E., Shaposhnikov, M. V., & Moskalev, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124484 · Cited by 45
Senescent endothelial cells: a potential target for diabetic retinopathy
Liao, Y.-L., Fang, Y., Sun, J., & Dou, G. (2024) · Angiogenesis · doi:10.1007/s10456-024-09943-7 · Cited by 45
“These studies further promote the development of internalized by SCs and subsequently activated by SA-β-gal [150 ].”
Mesoporous silicas in materials engineering: Nanodevices for bionanotechnologies
Mazzotta, E., Santo, M. D., Lombardo, D., Leggio, A., & Pasqua, L. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100472 · Cited by 48
“Gal-encapsulated cytotoxic drugs targeted senescent tumor cells and enhanced tumor xenograft regression in combination with palbociclib in a model of chemotherapy-induced senescence, furthermore, gal-encapsulated cytotoxics that targeted senescent cells, reduced collagen deposition and restored pulmonary function in a…”
BackgroundEffects of senescence on the tumour microenvironment and response to therapy
Reynolds, L. E., Maallin, S., Haston, S., Martínez-Barberá, J. P., Hodivala‐Dilke, K., & Pedrosa, A. (2023) · FEBS Journal · doi:10.1111/febs.16984 · Cited by 45
“Nanoparticles loaded with Palbociclib, and coated with galacto-oligosaccharides are internalised, enabling b -galactosidase to digest the galacto-oligosaccharides and release the nanoparticle contents within the senescent cells [99].”
Cellular Senescence in Immunity against Infections
Marrella, V., Facoetti, A., & Cassani, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911845 · Cited by 44
“Thus, although this strategy could suffer from off-target effects, lysosomal β-gal can be effectively leveraged to selectively eliminate immunosenescent cells [225].”
BackgroundInfluentialTargeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy
Jiang, B., Zhang, W., Zhang, X., & Sun, Y. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.05.002 · Cited by 39
Enhancing immunity during ageing by targeting interactions within the tissue environment
Bracken, O. V., Maeyer, R. P. H. D., & Akbar, A. N. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01126-9 · Cited by 45
Aryl hydrocarbon receptor: From pathogenesis to therapeutic targets in aging-related tissue fibrosis
Yang, C.-E., Wang, Y., Hua, M.-R., Miao, H., Zhao, Y., & Cao, G. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101662 · Cited by 36
Senescence in cancer: Advances in detection and treatment modalities
Billimoria, R., & Bhatt, P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115739 · Cited by 38
Nanocarriers for natural polyphenol senotherapeutics
Joma, N., Bielawski, P., Saini, A., Kakkar, A. K., & Maysinger, D. (2024) · Aging Cell · doi:10.1111/acel.14178 · Cited by 36
Vedova, L. D., Baron, G., Morazzoni, P., Aldini, G., & Gado, F. (2025) · Pharmaceuticals · doi:10.3390/ph18020138 · Cited by 43
“A second generation of senolytic drugs has been identified thanks to computational studies based on an increase in lysosomal mass and senescence-associated β -galactosidase activity, as well as targeting the modulation of immune clearance of SCs [37–39].”
Immunotherapy and senolytics in head and neck squamous cell carcinoma: phase 2 trial results
Liu, N., Wu, J., Deng, E., Zhong, J., Wei, B., Cai, T., Xie, Z., Duan, X., Fu, S., Osei-Hwedieh, D. O., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03873-7 · Cited by 47
“…senotherapeutics targeting novel mecha nisms—such as galactooligosaccharidecoated nanoparticles and βgalactosidaseactivated prodrugs designed to exploit the elevated lysosomal βgalactosidase activity in senescent cells 64,65 —provide diverse options for flexible senolytic applications.”
Chromo-fluorogenic probes for β-galactosidase detection
Lozano‐Torres, B., Blandez, J. F., Sancenón, F., & Martínez‐Máñez, R. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-03111-8 · Cited by 37
Self-citationAutophagy and senescence in cancer therapy
Patel, N. H., Bloukh, S., Alwohosh, E., Alhesa, A., Saleh, T., & Gewirtz, D. A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.002 · Cited by 42
Sphingomyelin nanosystems decorated with TSP-1 derived peptide targeting senescent cells
Jatal, R., Saraiva, S. M., Vázquez‐Vázquez, C., Lelièvre, E., Coqueret, O., López‐López, R., & de la Fuente, M. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121618 · Cited by 33
Nano-Based Theranostic Tools for the Detection and Elimination of Senescent Cells
Adamczyk‐Grochala, J., & Lewińska, A. (2020) · Cells · doi:10.3390/cells9122659 · Cited by 32
“For example, cargo release in the presence of β-galactosidase (β-gal) was due to the hydrolysis of the capping galacto-oligosaccharide (Gal) polymer [109].”
BackgroundInfluentialCharacterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic
Al-Mansour, F. S. H., Alraddadi, A. M., He, B., Saleh, A., Poblocka, M., Alzahrani, W., Cowley, S. M., & Macip, S. (2023) · Aging · doi:10.18632/aging.204616 · Cited by 30
Wang, Z., Chen, Y., Fang, H., Xiao, K., Wu, Z., Xie, X., Liu, J., Chen, F., He, Y., Wang, L., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp7022 · Cited by 41
“Senescence is a cellular response to various stress and damage signals, which is characterized as a physiological process to eliminate aberrant, damaged, or unwanted cells ( 20 – 22 ).”
BackgroundAn Indocyanine Green‐Based Nanoprobe for In Vivo Detection of Cellular Senescence
Baker, A. G., Hartono, M., Ou, H., Bistrović, A., Brown, E. L., Joseph, J., Golinska, M. A., González‐Gualda, E., Macías, D., Ge, J., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202404885 · Cited by 32
Self-citationWei, X., Zheng, Z., Liu, M., Yang, Z., Xie, E., Lin, J., Gao, Y., Tan, R., She, Z., Ma, J., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.10.015 · Cited by 32
Vivo‐Llorca, G., Candela‐Noguera, V., Alfonso, M., García‐Fernández, A., Orzáez, M., Sancenón, F., & Martínez‐Máñez, R. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202001579 · Cited by 31
Self-citationNishida, K., Nishimura, S., & Tanaka, M. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.1c01343 · Cited by 30
Carpintero-Fernández, P., Borghesan, M., Eleftheriadou, O., Pan‐Castillo, B., Fafián‐Labora, J., Mitchell, T. P., Yuste, A., Öğrünç, M., Nightingale, T. D., Mayán, M. D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04569-3 · Cited by 32
Wang, H., Yu, Y., Li, R., Zhang, H., Chen, Z., Sun, C., & Zhuang, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.022 · Cited by 43
“Furthermore, researchers have explored the use of galacto-oligosaccharide nanoparticle delivery systems to target senescent cells 194 .”
Reactive X (where X = O, N, S, C, Cl, Br, and I) species nanomedicine
Wang, K., Mao, W., Song, X., Chen, M., Feng, W., Peng, B., & Chen, Y. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00435f · Cited by 29
Wang, Y., Xie, F., He, Z., Che, L., Chen, X., Yuan, Y., & Liu, C. (2023) · Small · doi:10.1002/smll.202304433 · Cited by 32
Chen, B., Chai, Q., Xu, S., Li, Q., Wu, T., Chen, S., & Wu, L. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111070 · Cited by 28
The Expression of the Senescence-Associated Biomarker Lamin B1 in Human Breast Cancer
Saleh, T., Alhesa, A., El‐Sadoni, M., Shahin, N. A., Alsharaiah, E., Shboul, S. A., Awad, H., Bloukh, S., Al-Balas, M., Alsalem, M., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12030609 · Cited by 30
From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs
L’Hôte, V., Mann, C., & Thuret, J. (2022) · Open Biology · doi:10.1098/rsob.220171 · Cited by 31
Counteracting Immunosenescence—Which Therapeutic Strategies Are Promising?
Hieber, C., Grabbe, S., & Bros, M. (2023) · Biomolecules · doi:10.3390/biom13071085 · Cited by 30
Revolutionizing Diabetic Foot Ulcer Care: The Senotherapeutic Approach
Zhang, G., Samarawickrama, P. N., Gui, L., Ma, Y., Cao, M., Zhu, H., Li, W., Yang, H., Li, K., Yang, Y., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0065 · Cited by 32
Senolytics: Targeting Senescent Cells for Age-Associated Diseases
Al‐Naggar, I. M., Kuchel, G. A., & Xu, M. (2020) · Current Molecular Biology Reports · doi:10.1007/s40610-020-00140-1 · Cited by 32
“Muñoz-Espín et al described the use of nanoparticles coated with galacto-oligosaccharides and containing cytotoxic agents to specifically deliver poisons to senescent cells, many of which have a high lysosomal content and lysosomal βgalactosidase, allowing the digestion of the coat and release of the encapsulated drug…”
BackgroundMolecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
Mittermeier, C., Konopa, A., & Muehlich, S. (2020) · Cells · doi:10.3390/cells9122540 · Cited by 30
Chu, J. C. H., Xiong, J., Wong, C. T. T., Wang, S., Tam, D. Y., García‐Fernández, A., Martínez‐Máñez, R., & Ng, D. K. P. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01306 · Cited by 27
Self-citationOzdemir, S. A., Faizan, M. I., Kaur, G., Shaikh, S. B., Islam, K. U., & Rahman, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199687 · Cited by 34
Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?
Kim, C.-K., Sachdev, P. S., & Braidy, N. (2022) · Aging and Disease · doi:10.14336/ad.2021.0705 · Cited by 32
“As well, the fate of senescent cells and regenerative processes in the body are nascent in the current literature [219].”
BackgroundImpact of senolytic treatment on immunity, aging, and disease
Lorenzo, E. C., Torrance, B. L., & Haynes, L. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1161799 · Cited by 31
Cellular senescence and frailty: a comprehensive insight into the causal links
Marcozzi, S., Bigossi, G., Giuliani, M. E., Giacconi, R., Piacenza, F., Cardelli, M., Brunetti, D., Segala, A., Valerio, A., Nisoli, E., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00960-w · Cited by 28
“The genetic [109] and senolytic (galacto-encapsu-lated doxorubicin) [110] removal of senescent cells in mouse models of bleomycin-induced pulmonary fibrosis led to various improvements in pulmonary function.”
BackgroundNeutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells
Favaretto, G., Rossi, M. N., Cuollo, L., Laffranchi, M., Cervelli, M., Soriani, A., Sozzani, S., Santoni, A., & Antonangeli, F. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03695-5 · Cited by 26
Senotherapeutics for mesenchymal stem cell senescence and rejuvenation
Wong, P., Murugan, D. D., & Ramasamy, T. S. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103424 · Cited by 27
Dhokia, V., Albati, A., Smith, H., Thomas, G., & Macip, S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231066 · Cited by 26
Xin, Y., Yuan, Z., Wang, J., & Li, S. (2025) · The FASEB Journal · doi:10.1096/fj.202500244rrr · Cited by 36
“For instance, galacto- oligosaccharide-encapsulated nanoparticles have been designed to selectively deliver cytotoxic agents or senolytics [133], effectively eliminating senescent cells.”
Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy
Yang, H., Liu, D., Qiu, L., Wang, R., Zhang, C., Yu, D., Zhong, Q., Yuki, N., Song, Z., Zhu, Τ., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02459-8 · Cited by 38
“Three preclinically validated targeted strategies address this: GalNPs [298]: ~100 nm silica nanoparticles coated with 6-mer β(1,4)-galacto-oligosaccharides, encapsulating cytotoxics (doxorubicin, navitoclax).”
The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence
Liao, C., Xiao, Y., & Liu, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s285083 · Cited by 26
“using galactooligosaccharides–coated nanoparticles containing senolytics when administered in a chronic manner.(80)”
MethodThe context-dependent effect of cellular senescence: From embryogenesis and wound healing to aging
Lavarti, R., Alvarez-Diaz, T., Marti, K., Kar, P., & Raju, R. P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102760 · Cited by 21
Therapeutic strategies targeting cellular senescence for cancer and other diseases
Wang, X., Fukumoto, T., & Noma, K.-I. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae015 · Cited by 29
“As described in the aforementioned section, ABT-263 has a platelet toxicity (107, 108) , and improved ABT-263, Nav-Gal and GalNP(nav) can selectively remove senescent lung cancer and melanoma cells, which are derived from treatment with cisplatin and palbociclib, respectively (86, 87) .”
BackgroundChu, J. C. H., Escriche‐Navarro, B., Xiong, J., García‐Fernández, A., Martínez‐Máñez, R., & Ng, D. K. P. (2024) · Advanced Science · doi:10.1002/advs.202401012 · Cited by 21
Self-citationCell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases
Deng, S., Xie, H., & Xie, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04285-7 · Cited by 28
“Muñoz-Espín et al. describes an innovative approach that takes advantage of the high lysosomal β-galactosidase activity in senescent cells to design a drug delivery system using galacto-oligosaccharides [37].”
Key Molecular Mechanisms of Aging, Biomarkers, and Potential Interventions
Proshkina, E., Solovev, I. A., Shaposhnikov, M. V., & Moskalev, A. (2020) · Molecular Biology · doi:10.1134/s0026893320060096 · Cited by 21
Venkataraman, A., Kordic, I., Li, J., Zhang, N. Y., Bharadwaj, N. S., Fang, Z., Das, S., & Coskun, A. F. (2024) · npj Aging · doi:10.1038/s41514-024-00178-w · Cited by 23
New Trends in Aging Drug Discovery
Benhamú, B., Martín‐Fontecha, M., Vázquez‐Villa, H., López-Rodríguez, M. L., & Ortega‐Gutiérrez, S. (2022) · Biomedicines · doi:10.3390/biomedicines10082006 · Cited by 22
“Based on a similar approach, nanoparticles containing cytotoxic compounds coated with galacto-oligosaccharides on a silica scaffold have been employed to selectively deliver cytotoxic compounds to SnCs [5].”
BackgroundEstepa‐Fernández, A., García‐Fernández, A., Lérida‐Viso, A., Morellá‐Aucejo, Á., Esteve‐Moreno, J. J., Blandez, J. F., Alfonso, M., Candela‐Noguera, V., Vivo‐Llorca, G., Sancenón, F., et al. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101692 · Cited by 19
Self-citationHou, S., Lai, C., Song, Y., Wang, H., Ni, J., & Tan, M. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250058 · Cited by 19
Cellular senescence: A novel therapeutic target for central nervous system diseases
Lei, S.-Y., Qu, Y., Yang, Y.-Q., Liu, J., Zhang, Y.-F., Zhou, S., He, Q., Jin, H., Yang, Y., & Guo, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117311 · Cited by 23
Cellular plasticity and metastasis in breast cancer: a pre- and post-malignant problem
Smigiel, J. M., Taylor, S. E., Bryson, B. L., Tamagno, I., Polak, K. L., & Jackson, M. W. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2019.26 · Cited by 20
“Preclinical results showed a significant regression of tumor xenografts after treatment with galNP beads loaded with doxorubicin in combination with palbociclib([263]).”
BackgroundRad, A. N., Shams, G., Safdarian, M., Khorsandi, L., Grillari, J., & Makhmalzadeh, B. S. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119603 · Cited by 22
Senescent cells in the brain and where to find them
Rachmian, N., & Krizhanovsky, V. (2022) · FEBS Journal · doi:10.1111/febs.16649 · Cited by 20
Advances in Nanotherapy for Targeting Senescent Cells
Shi, Y., Zhang, Y., Zhang, Y., Yao, J., Guo, J., Xu, X., & Wang, L. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s469110 · Cited by 23
“62 Currently, progress has been made in the development of nanoparticles for diagnosis and treatment, including mesoporous calcium carbonate nanoparticles, mesoporous silica nanoparticles, carbon quantum dots, iron oxide, and molecularly imprinted polymer nanoparticles, which can encapsulate…”
BackgroundSenolysis Reduces Senescence in Veins and Cancer Cell Migration
Estepa‐Fernández, A., Alfonso, M., Morellá‐Aucejo, Á., García‐Fernández, A., Lérida‐Viso, A., Lozano‐Torres, B., Galiana, I., Soriano‐Teruel, P. M., Sancenón, F., Orzáez, M., et al. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100149 · Cited by 19
Self-citationParshad, B., Baker, A. G., Ahmed, I., Estepa‐Fernández, A., Muñoz‐Espín, D., & Fruk, L. (2024) · Small · doi:10.1002/smll.202405732 · Cited by 21
Self-citationКлючевые молекулярные механизмы старения, биомаркеры и потенциальные интервенции
Proshkina, E., Соловьёв, И. А., Shaposhnikov, M. V., & Moskalev, A. A. (2020) · Molecular Biology · doi:10.31857/s0026898420060099 · Cited by 21
High-Capacity Mesoporous Silica Nanocarriers of siRNA for Applications in Retinal Delivery
Ultimo, A., Orzáez, M., Santos-Martínez, M. J., Martínez‐Máñez, R., Marcos, M. D., Sancenón, F., & Ruiz‐Hernández, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032753 · Cited by 18
Self-citationBanerjee, P., Gaddam, N., Pandita, T. K., & Chakraborty, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032877 · Cited by 21
Emerging role of cellular senescence in normal lung development and perinatal lung injury
Dennery, P. A., & Yao, H. (2024) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2024.01.001 · Cited by 20
“67 , 69 , 70 For instance, a recent study designed a new prodrug SSK1 based on elevated 𝛽 -gal, a major senescence marker, to direct gemcitabine and kill senescent cells in a highly selective manner.”
BackgroundNanocarriers targeting senescent cells
Muñoz‐Espín, D. (2019) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.01.001 · Cited by 18
Self-citationSenescence, Aging and Disease Throughout the Gastrointestinal System
Ferreira-González, S., Matsumoto, T., Hara, E., & Forbes, S. J. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.06.010 · Cited by 20
Silva, E. D., Tomé, I., Vasques‐Nóvoa, F., Conceição, G., da Silva, A. M., Barros, A. S., Mendes‐Ferreira, P., Santos-Ribeiro, D., Gonçalves, A., Angélico‐Gonçalves, A., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf208 · Cited by 19
“To mitigate these concerns, new pharmacological strategies are being developed to enhance both safety and efficacy, including the use of senolytic nanoparticles 58 and senolytic prodrugs.”
Senotherapy for chronic lung disease
Barnes, P. J. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100069 · Cited by 18
Wu, H., Zhang, Q., Zhu, J., Wu, L., Xiao, Y., & Yang, X. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.09.002 · Cited by 35
Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerability
D’Ambrosio, M., White, M. E. H., Gavriil, E.-S., Bousset, L., Birch, J., Gruevska, A., Pasquini, E., Colucci, M., Fong, W., Mosole, S., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01921-z · Cited by 17
Sun, Y. (2023) · Translational Medicine of Aging · doi:10.1016/j.tma.2023.06.001 · Cited by 16
Targeting Senescent Cells as Therapy for CKD
Mylonas, K. J., & Ferenbach, D. A. (2023) · Kidney360 · doi:10.34067/kid.0000000000000316 · Cited by 23
Translating cellular senescence research into clinical practice for metabolic disease
Chaib, S., Palmer, A. K., Wyles, S. P., Musi, N., Kirkland, J. L., & Tchkonia, T. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01187-9 · Cited by 18
Self-citationLee, S. K., Shen, Z., Han, M. S., & Tung, C. (2022) · RSC Advances · doi:10.1039/d2ra00377e · Cited by 15
Zhou, H., Zheng, Z., Fan, C., & Zhou, Z. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.01.001 · Cited by 21
Metadata
- Authors
- Muñoz‐Espín, D., Rovira, M., Galiana, I., Giménez, C., Lozano‐Torres, B., Paez‐Ribes, M., Llanos, S., Chaib, S., Muñoz‐Martín, M., Ucero, A. C., Garaulet, G., Mulero, F., Dann, S. G., VanArsdale, T., Shields, D. J., Bernardos, A., Murguía, J. R., Martínez‐Máñez, R., & Serrano, M.
- Affiliations
- University of Cambridge (GB)
- Spanish National Cancer Research Centre (ES)
- Universitat de València (ES)
- Pfizer (United States) (US)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Muñoz‐Espín, Daniel
- Serrano, Manuel
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2018-07-16
- Volume
- 10
- Issue
- 9
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC6127887
- OpenAlex
- W2884253843
- Cited by
- 339
- References
- 64
- Citations by year
- 2026: 33 · 2025: 48 · 2024: 52 · 2023: 45 · 2022: 48 · 2021: 28 · 2020: 52 · 2019: 31 · 2018: 2
- FWCI
- 19.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- RiuNet (Universitat Politècnica de València) (submittedVersion, cc-by-nc-nd)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Secretaría de Estado de Investigación, Desarrollo e Innovación (MAT2015‐64139‐C4‐1‐R)
- H2020 European Research Council
- Instituto de Salud Carlos III (DTS16/00205)
- European Regional Development Fund
- European Social Fund
- Institut Ruđer Bošković
- Fundación Botín
- Banco Santander
- “la Caixa” Foundation
- Cancer Research UK (C9685‐A25177, RG86786)
- Generalitat Valenciana (PROMETEOII/2014/047)
- Pfizer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- senolytics, senescent cells, drug delivery systems, galactooligosaccharides, lysosomal beta-galactosidase, chemotherapy-induced senescence, palbociclib, age-related diseases
- MeSH terms
- Animals, beta-Galactosidase, Cell Survival, Cytotoxins, Disease Models, Animal, Drug Compounding, Fluorescent Dyes, Galactose, Lysosomes, Neoplasm Transplantation, Neoplasms, Oligosaccharides, Piperazines, Pyridines, Staining and Labeling, Drug Delivery Systems, Cellular Senescence, Mice, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.